MENU
+Compare
KRON
Stock ticker: NASDAQ
AS OF
Apr 17 closing price
Price
$0.89
Change
+$0.01 (+1.14%)
Capitalization
54.14M

KRON Kronos Bio Forecast, Technical & Fundamental Analysis

Kronos Bio Inc is a clinical-stage biopharmaceutical company... Show more

KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for KRON with price predictions
Apr 17, 2025

KRON in upward trend: price may ascend as a result of having broken its lower Bollinger Band on March 19, 2025

KRON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 39 cases where KRON's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where KRON's RSI Oscillator exited the oversold zone, of 45 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 14, 2025. You may want to consider a long position or call options on KRON as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KRON just turned positive on April 14, 2025. Looking at past instances where KRON's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KRON advanced for three days, in of 196 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KRON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KRON entered a downward trend on April 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.618) is normal, around the industry mean (13.444). P/E Ratio (0.000) is within average values for comparable stocks, (62.833). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.754). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. P/S Ratio (5.417) is also within normal values, averaging (250.783).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. KRON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KRON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KRON is expected to report earnings to fall 30.23% to -30 cents per share on May 07

Kronos Bio KRON Stock Earnings Reports
Q1'25
Est.
$-0.30
Q4'24
Missed
by $0.17
Q3'24
Beat
by $0.05
Q2'24
Beat
by $0.09
Q1'24
Missed
by $0.08
The last earnings report on March 18 showed earnings per share of -43 cents, missing the estimate of -25 cents. With 11.03K shares outstanding, the current market capitalization sits at 54.14M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1300 So. El Camino Real
Phone
+1 650 781-5200
Employees
62
Web
https://www.kronosbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla
BTC.X84450.805000-444.945300
-0.52%
Bitcoin cryptocurrency

KRON and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KRON has been loosely correlated with VSTM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if KRON jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRON
1D Price
Change %
KRON100%
+0.91%
VSTM - KRON
35%
Loosely correlated
+15.73%
LENZ - KRON
33%
Loosely correlated
+3.30%
IPSC - KRON
32%
Poorly correlated
+8.74%
TNXP - KRON
31%
Poorly correlated
N/A
SNSE - KRON
30%
Poorly correlated
-3.34%
More